JANUARY BLALOCK: Open Payments
NPI 1902344658 · RAINSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $288 · 2025 $262
Food & beverage: $193Education: $69
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Astellas Pharma US Inc | 1 | $69 |
| Novo Nordisk Inc | 2 | $44 |
| Atland Pharmaceuticals, LLC | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: REXULTI, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Ozempic, OTEZLA, Kerendia.
Industry payments across AL — which companies pay providers there.
